Overview

Myocardial viability has become an important issue in clinical cardiology. In particular, absence or presence of viability may be decisive in patient management, and the decision to perform angioplasty (PTCA) or bypass surgery (CABG) is frequently based on the accurate assessment of viability. Although echocardiography and conventional nuclear medicine techniques may provide valuable information on viability, positron emission tomography (PET) is currently considered to be the standard for the assessment of myocardial viability. The simultaneous evaluation of myocardial metabolism and perfusion allows precise delineation and accurate quantification of residual myocardial viability in affected regions. In addition, accurate quantification of myocardial perfusion alone may provide insight into the basic mechanisms of ""syndrome X"" and may assist in the appropriate clarification of this clinically complicated, but frequently occurring, phenomenon. Besides that, cardiac PET may deepen insight into metabolism and perfusion of cardiac muscle disease, particularly in hypertrophic cardiomyopathy. Furthermore, receptor imaging studies with PET will become important as the study of cardiac neurohumoral regulation in heart failure has gained in interest. This text describes the most recent developments in cardiac PET as these are related to myocardial viability and myocardial perfusion studies of ""syndrome X"". The value of PET for receptor imaging and cardiac muscle disease is also discussed.

Full Product Details

Author:   E. E. van der Wall ,  P. K. Blanksma ,  M. G. Niemeyer ,  A. M. Paans
Publisher:   Kluwer Academic Publishers
Imprint:   Kluwer Academic Publishers
Volume:   v. 166
ISBN:  

9780792334729

ISBN 10:   0792334728
Pages:   276
Publication Date:   31 May 1995
Audience:   College/higher education ,  Professional and scholarly ,  Postgraduate, Research & Scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Out of stock  
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Table of Contents

Part One: Myocardial Viability. 1. Myocardial viability: stunning and hibernation; W. Flameng, B. Shivalkar, M. Borgers. 2. Positron emission tomography assessment of myocardial viability; Eng-Shiong Tan. 3. Comparison of thallium scintigraphy and positron emission tomography; M.G. Niemeyer, J.G. Meeder, A.F.M. Kuijper, P.K. Blanksma, E.E. van der Wall. 4. Cardiac metabolism: positron emission tomography versus single photon emission computed tomography; E.E. van der Wall. 5. The role of fluorine-19-deoxyglucose single photon emission computed tomography in predicting reversibility of regional wall motion abnormalities after revascularization; J.J. Bax, J.H. Cornel, F.C. Visser, P.M. Fioretti, A. van Lingen, J.M. Huitink, O. Kamp, G.J.J. Teule, C.A. Visser. 6. Parametric positron emission tomography imaging of myocardial perfusion and metabolism; A.T.M. Willemsen, P.K. Blanksma, A.M.J. Paans. 7. Postron emission tomography compared to single photo emission computed tomography in the evaluation of myocardial viability: a preliminary cost-effectiveness analysis; M.G.M. Hunink. 8. Assessment of myocardial viability by pharmacological stress echocardiography; J.H. Cornel, M.P. Fioretti. 9. Assessment of myocardial viability by magnetic resonance imaging techniques; C.A. Schneider, F. Baer, E. Voth, P. Theissen, U. Sechtem. Part Two: Hypertrophic Cardiomyopathy. 10. Classification of hypertrophic cardiomyopathy with magnetic resonance imaging compared with echocardiography; J.L. Posma, P.K. Blanksma, Kong I. Lie. 11. Positron emission tomography characterization of the myocardium in hypertrophic cardiomyopathy; P.K. Blanksma, J.L. Posma, R.M. de Jong, J. Pruim, A.T.M. Willemsen, R.L. Anthonio, E. van der Wall, W. Vaalburg, Kong I. Lie. 12. Treatment of hypertrophic obstructive cardiomyopathy with pacing; L. Kappenberger, X. Jeanrenaud, N. Aebischer. Part Three: Receptor Imaging Studies. 13. Heart failure and the cardiac beta-adrenoceptor; O.-E. Brodde. 14. Study of cardiac receptor ligands by positron emission tomography; A. van Waarde, P.H. Elsinga, R.L. Anthonio, T.J. Visser, P.K. Blanksma, G.M. Visser, A.M.J. Paans, W. Vaalburg. 15. Assessment of sympathetic cardiac innervation by scintigraphic techniques; G. Munch, Ngoc Nguyen, D. Wieland, M. Schwaiger. 16. Experimental and clinical cardiac beta-receptor studies; R.L. Anthonio, A. van Waarde, A.T.M. Willemsen, J. Pruim, W.H. van Gilst, P.K. Blanksma, W. Vaalburg, Kong I. Lie. Part Four: Myocardial Perfusion. 17. Methodological issues in regional myocardial perfusion imaging with positron emission tomography; A. Bol, W. Wijns, J.A. Melin. (Part contents).

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions